NVO

New Obesity Drug Could Launch in U.S. Before 2015

Danish drug-maker Novo Nordisk says its anti-obesity treatment liraglutide could become available for sale in the U.S. by the end of 2014. More 

AAPL Is Still Sour; Look for New Opportunities

The markets are in the middle of a strong rally, and a resurgent Apple is helping to lead the way. I still think it's a stock to sell. More 

3 Call Contenders in Pharmaceuticals

These pharmaceutical stocks are doing something right--all have shown up as strong buys on my Power Stock scanner. More 

6 Call Contenders Releasing Earnings

These bullish stocks are all reporting this week -- why not take advantage with call options? More 

Get Ready For the Next Dividend Rush

A dividend rush is on as companies begin to go ex-dividend. Here is a list to follow on companies with dividend payments coming up More 

4 Pharma Stocks to Sell

Sell these four bitter pills before they make your profits sicken. More 

5 Stocks You Should Have Sold Yesterday

These stocks have low volatility and there seems to be only downside left. Make sure you sell these stinkers now if you're unlucky enough to own them. More